TRLS.LSE Trellus Health plc

Healthcare Health Care Equipment & Supplies London Exchange
0.0012 GBX
Close of Nov 3, 2026
0.0400 1.75
Market cap
GBX 516K
P/E
-
P/B
0.08x
ROE
-137.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2025.

Is TRLS.LSE undervalued?

Graham number

The Graham number of Trellus Health plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Trellus Health plc fundamental analysis

No fundamental analysis for Trellus Health plc yet.

Trellus Health plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Trellus Health plc

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.

Full company profile